This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnston, N. J.
Right arrow Articles by Low, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnston, N. J.
Right arrow Articles by Low, D. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 1998, p. 2425-2426, Vol. 42, No. 9
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Prevalence and Characterization of the Mechanisms of Macrolide, Lincosamide, and Streptogramin Resistance in Isolates of Streptococcus pneumoniae

Nicole J. Johnston,1 Joyce C. de Azavedo,1 James D. Kellner,2 and Donald E. Low1,*

Department of Microbiology, Mount Sinai and Princess Margaret Hospitals, and the University of Toronto, Toronto, Ontario,1 and Alberta Children's Hospital and the University of Calgary, Calgary, Alberta,2 Canada

Received 19 September 1997/Returned for modification 16 January 1998/Accepted 16 June 1998

Of a total of 147 erythromycin-resistant Streptococcus pneumoniae isolates, 64 (43.5%) were resistant to erythromycin, clindamycin, and streptogramin B (MLSB phenotype), 57 of which possessed the ermB gene. Eighty-two (55.8%) were resistant to erythromycin alone (M phenotype), 81 of which possessed the mefE gene. One was erythromycin and streptogramin B resistant but susceptible to clindamycin (MS phenotype) and possessed neither the erm gene nor the mefE gene.


* Corresponding author. Mailing address: Department of Microbiology, Mount Sinai Hospital, 600 University Ave., Toronto, Ontario M5G 1X5, Canada. Phone: (416) 586-4435. Fax: (416) 586-8746. E-mail: dlow{at}mtsinai.on.ca.


Antimicrobial Agents and Chemotherapy, September 1998, p. 2425-2426, Vol. 42, No. 9
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Savini, V., Favaro, M., Fontana, C., Consilvio, N. P., Manna, A., Talia, M., Catavitello, C., Balbinot, A., Febbo, F., Di Bonaventura, G., Di Giuseppe, N., D'Antonio, D. (2008). A case of pharyngitis caused by Streptococcus pneumoniae. J Med Microbiol 57: 674-675 [Abstract] [Full Text]  
  • Wierzbowski, A. K., Nichol, K., Laing, N., Hisanaga, T., Nikulin, A., Karlowsky, J. A., Hoban, D. J., Zhanel, G. G. (2007). Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004). J Antimicrob Chemother 60: 733-740 [Abstract] [Full Text]  
  • Ambrose, K. D., Nisbet, R., Stephens, D. S. (2005). Macrolide Efflux in Streptococcus pneumoniae Is Mediated by a Dual Efflux Pump (mel and mef) and Is Erythromycin Inducible. Antimicrob. Agents Chemother. 49: 4203-4209 [Abstract] [Full Text]  
  • Littauer, P., Sangvik, M., Caugant, D. A., Hoiby, E. A., Simonsen, G. S., Sundsfjord, A., the Norwegian Macrolide Study Group, (2005). Molecular Epidemiology of Macrolide-Resistant Isolates of Streptococcus pneumoniae Collected from Blood and Respiratory Specimens in Norway. J. Clin. Microbiol. 43: 2125-2132 [Abstract] [Full Text]  
  • Klaassen, C. H. W., Mouton, J. W. (2005). Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E). Antimicrob. Agents Chemother. 49: 1271-1278 [Full Text]  
  • Brown, S. D., Farrell, D. J., Morrissey, I. (2004). Prevalence and Molecular Analysis of Macrolide and Fluoroquinolone Resistance among Isolates of Streptococcus pneumoniae Collected during the 2000-2001 PROTEKT US Study. J. Clin. Microbiol. 42: 4980-4987 [Abstract] [Full Text]  
  • Tiemei, Z., Xiangqun, F., Youning, L. (2004). Resistance Phenotypes and Genotypes of Erythromycin-Resistant Streptococcus pneumoniae Isolates in Beijing and Shenyang, China. Antimicrob. Agents Chemother. 48: 4040-4041 [Abstract] [Full Text]  
  • Powis, J., McGeer, A., Green, K., Vanderkooi, O., Weiss, K., Zhanel, G., Mazzulli, T., Kuhn, M., Church, D., Davidson, R., Forward, K., Hoban, D., Simor, A., Low, D. E. (2004). In Vitro Antimicrobial Susceptibilities of Streptococcus pneumoniae Clinical Isolates Obtained in Canada in 2002. Antimicrob. Agents Chemother. 48: 3305-3311 [Abstract] [Full Text]  
  • Song, J.-H., Chang, H.-H., Suh, J. Y., Ko, K. S., Jung, S.-I., Oh, W. S., Peck, K. R., Lee, N. Y., Yang, Y., Chongthaleong, A., Aswapokee, N., Chiu, C.-H., Lalitha, M. K., Perera, J., Yee, T. T., Kumararasinghe, G., Jamal, F., Kamarulazaman, A., Parasakthi, N., Van, P. H., So, T., Ng, T. K., on behalf of the ANSORP Study Group, (2004). Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). J Antimicrob Chemother 53: 457-463 [Abstract] [Full Text]  
  • Pihlajamaki, M., Jalava, J., Huovinen, P., Kotilainen, P. (2003). Antimicrobial Resistance of Invasive Pneumococci in Finland in 1999-2000. Antimicrob. Agents Chemother. 47: 1832-1835 [Abstract] [Full Text]  
  • Reinert, R. R., Lutticken, R., Bryskier, A., Al-Lahham, A. (2003). Macrolide-Resistant Streptococcus pneumoniae and Streptococcus pyogenes in the Pediatric Population in Germany during 2000-2001. Antimicrob. Agents Chemother. 47: 489-493 [Abstract] [Full Text]  
  • Liu, M., Douthwaite, S. (2002). Resistance to the macrolide antibiotic tylosin is conferred by single methylations at 23S rRNA nucleotides G748 and A2058 acting in synergy. Proc. Natl. Acad. Sci. USA 99: 14658-14663 [Abstract] [Full Text]  
  • Weiss, K., Guilbault, C., Cortes, L., Restieri, C., Low, D. E., the EQUERE project (Etude QUEbecoise des pathogene, (2002). Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin. J Antimicrob Chemother 50: 403-406 [Abstract] [Full Text]  
  • Pihlajamaki, M., Kaijalainen, T., Huovinen, P., Jalava, J., the Finnish Study Group for Antimicrobial Resistan, (2002). Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996-2000. J Antimicrob Chemother 49: 785-792 [Abstract] [Full Text]  
  • Low, D. E., de Azavedo, J., Weiss, K., Mazzulli, T., Kuhn, M., Church, D., Forward, K., Zhanel, G., Simor, A., McGeer, A. (2002). Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob. Agents Chemother. 46: 1295-1301 [Abstract] [Full Text]  
  • Lim, J.-A., Kwon, A.-R., Kim, S.-K., Chong, Y., Lee, K., Choi, E.-C. (2002). Prevalence of resistance to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in a Korean hospital. J Antimicrob Chemother 49: 489-495 [Abstract] [Full Text]  
  • Del Grosso, M., Iannelli, F., Messina, C., Santagati, M., Petrosillo, N., Stefani, S., Pozzi, G., Pantosti, A. (2002). Macrolide Efflux Genes mef(A) and mef(E) Are Carried by Different Genetic Elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40: 774-778 [Abstract] [Full Text]  
  • Canu, A., Malbruny, B., Coquemont, M., Davies, T. A., Appelbaum, P. C., Leclercq, R. (2002). Diversity of Ribosomal Mutations Conferring Resistance to Macrolides, Clindamycin, Streptogramin, and Telithromycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46: 125-131 [Abstract] [Full Text]  
  • de Azavedo, J. C. S., McGavin, M., Duncan, C., Low, D. E., McGeer, A. (2001). Prevalence and Mechanisms of Macrolide Resistance in Invasive and Noninvasive Group B Streptococcus Isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45: 3504-3508 [Abstract] [Full Text]  
  • Singh, K. V., Malathum, K., Murray, B. E. (2001). In Vitro Activities of a New Ketolide, ABT-773, against Multidrug-Resistant Gram-Positive Cocci. Antimicrob. Agents Chemother. 45: 3640-3643 [Abstract] [Full Text]  
  • Hyde, T. B., Gay, K., Stephens, D. S., Vugia, D. J., Pass, M., Johnson, S., Barrett, N. L., Schaffner, W., Cieslak, P. R., Maupin, P. S., Zell, E. R., Jorgensen, J. H., Facklam, R. R., Whitney, C. G., for the Active Bacterial Core Surveillance/Emergin, (2001). Macrolide Resistance Among Invasive Streptococcus pneumoniae Isolates. JAMA 286: 1857-1862 [Abstract] [Full Text]  
  • Fluit, A. C., Visser, M. R., Schmitz, F.-J. (2001). Molecular Detection of Antimicrobial Resistance. Clin. Microbiol. Rev. 14: 836-871 [Abstract] [Full Text]  
  • Aracil, B., Minambres, M., Oteo, J., Torres, C., Gomez-Garces, J. L., Alos, J. I. (2001). High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria. J Antimicrob Chemother 48: 592-594 [Full Text]  
  • Weiss, K., de Azavedo, J., Restieri, C., Quach, C., Laverdiere, M., Rubin, E., Gourdeau, M., Low, D. E. (2001). In vitro activity of a novel ketolide ABT-773 against invasive strains of Streptococcus pneumoniae. J Antimicrob Chemother 48: 407-409 [Abstract] [Full Text]  
  • Mitten, M. J., Meulbroek, J., Nukkala, M., Paige, L., Jarvis, K., Oleksijew, A., Tovcimak, A., Hernandez, L., Alder, J. D., Ewing, P., Or, Y. S., Ma, Z., Nilius, A. M., Mollison, K., Flamm, R. K. (2001). Efficacies of ABT-773, a New Ketolide, against Experimental Bacterial Infections. Antimicrob. Agents Chemother. 45: 2585-2593 [Abstract] [Full Text]  
  • Perez-Trallero, E., Vicente, D., Montes, M., Marimon, J. M., Pineiro, L. (2001). High proportion of pharyngeal carriers of commensal streptococci resistant to erythromycin in Spanish adults. J Antimicrob Chemother 48: 225-229 [Abstract] [Full Text]  
  • Hoban, D. J., Wierzbowski, A. K., Nichol, K., Zhanel, G. G. (2001). Macrolide-Resistant Streptococcus pneumoniae in Canada during 1998-1999: Prevalence of mef(A) and erm(B) and Susceptibilities to Ketolides. Antimicrob. Agents Chemother. 45: 2147-2150 [Abstract] [Full Text]  
  • Doern, G. V., Heilmann, K. P., Huynh, H. K., Rhomberg, P. R., Coffman, S. L., Brueggemann, A. B. (2001). Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999-2000, Including a Comparison of Resistance Rates since 1994-1995. Antimicrob. Agents Chemother. 45: 1721-1729 [Abstract] [Full Text]  
  • Fitoussi, F., Loukil, C., Gros, I., Clermont, O., Mariani, P., Bonacorsi, S., Le Thomas, I., Deforche, D., Bingen, E. (2001). Mechanisms of Macrolide Resistance in Clinical Group B Streptococci Isolated in France. Antimicrob. Agents Chemother. 45: 1889-1891 [Abstract] [Full Text]  
  • Martin, S. J., Garvin, C. G., McBurney, C. R., Sahloff, E. G. (2001). The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 47: 581-587 [Abstract] [Full Text]  
  • Ip, M., Lyon, D. J., Yung, R. W. H., Chan, C., Cheng, A. F. B. (2001). Macrolide Resistance in Streptococcus pneumoniae in Hong Kong. Antimicrob. Agents Chemother. 45: 1578-1580 [Abstract] [Full Text]  
  • McGee, L., Klugman, K. P., Wasas, A., Capper, T., Brink, A., The Antibiotics Surveillance Forum Of South Africa, (2001). Serotype 19F Multiresistant Pneumococcal Clone Harboring Two Erythromycin Resistance Determinants [erm(B) and mef(A)] in South Africa. Antimicrob. Agents Chemother. 45: 1595-1598 [Abstract] [Full Text]  
  • Jalava, J., Kataja, J., Seppälä, H., Huovinen, P. (2001). In Vitro Activities of the Novel Ketolide Telithromycin (HMR 3647) against Erythromycin-Resistant Streptococcus Species. Antimicrob. Agents Chemother. 45: 789-793 [Abstract] [Full Text]  
  • Fitoussi, F., Doit, C., Geslin, P., Brahimi, N., Bingen, E. (2001). Mechanisms of Macrolide Resistance in Clinical Pneumococcal Isolates in France. Antimicrob. Agents Chemother. 45: 636-638 [Abstract] [Full Text]  
  • Tait-Kamradt, A., Davies, T., Appelbaum, P. C., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., Sutcliffe, J. (2000). Two New Mechanisms of Macrolide Resistance in Clinical Strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob. Agents Chemother. 44: 3395-3401 [Abstract] [Full Text]  
  • Betriu, C., Redondo, M., Palau, M. L., Sánchez, A., Gómez, M., Culebras, E., Boloix, A., Picazo, J. J. (2000). Comparative In Vitro Activities of Linezolid, Quinupristin-Dalfopristin, Moxifloxacin, and Trovafloxacin against Erythromycin-Susceptible and -Resistant Streptococci. Antimicrob. Agents Chemother. 44: 1838-1841 [Abstract] [Full Text]  
  • Capobianco, J. O., Cao, Z., Shortridge, V. D., Ma, Z., Flamm, R. K., Zhong, P. (2000). Studies of the Novel Ketolide ABT-773: Transport, Binding to Ribosomes, and Inhibition of Protein Synthesis in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44: 1562-1567 [Abstract] [Full Text]  
  • Portillo, A., Ruiz-Larrea, F., Zarazaga, M., Alonso, A., Martinez, J. L., Torres, C. (2000). Macrolide Resistance Genes in Enterococcus spp.. Antimicrob. Agents Chemother. 44: 967-971 [Abstract] [Full Text]  
  • Perez-Trallero, E. (2000). Pneumococcal macrolide resistance--not a myth. J Antimicrob Chemother 45: 401-402 [Full Text]  
  • Davies, T. A., Dewasse, B. E., Jacobs, M. R., Appelbaum, P. C. (2000). In Vitro Development of Resistance to Telithromycin (HMR 3647), Four Macrolides, Clindamycin, and Pristinamycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44: 414-417 [Abstract] [Full Text]  
  • Brueggemann, A. B., Doern, G. V., Huynh, H. K., Wingert, E. M., Rhomberg, P. R. (2000). In Vitro Activity of ABT-773, a New Ketolide, against Recent Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob. Agents Chemother. 44: 447-449 [Abstract] [Full Text]  
  • Descheemaeker, P., Chapelle, S., Lammens, C., Hauchecorne, M., Wijdooghe, M., Vandamme, P., Ieven, M., Goossens, H. (2000). Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. J Antimicrob Chemother 45: 167-173 [Abstract] [Full Text]  
  • Lagrou, K., Peetermans, W. E., Verhaegen, J., Van Lierde, S., Verbist, L., Van Eldere, J. (2000). Macrolide resistance in Belgian Streptococcus pneumoniae. J Antimicrob Chemother 45: 119-121 [Abstract] [Full Text]  
  • Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J., Seppala, H. (1999). Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants. Antimicrob. Agents Chemother. 43: 2823-2830 [Full Text]  
  • Marchese, A., Tonoli, E., Debbia, E. A., Schito, G. C. (1999). Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy. J Antimicrob Chemother 44: 461-464 [Abstract] [Full Text]  
  • Oster, P., Zanchi, A., Cresti, S., Lattanzi, M., Montagnani, F., Cellesi, C., Rossolini, G. M. (1999). Patterns of Macrolide Resistance Determinants among Community-Acquired Streptococcus pneumoniae Isolates over a 5-Year Period of Decreased Macrolide Susceptibility Rates. Antimicrob. Agents Chemother. 43: 2510-2512 [Abstract] [Full Text]  
  • De Azavedo, J. C. S., Yeung, R. H., Bast, D. J., Duncan, C. L., Borgia, S. B., Low, D. E. (1999). Prevalence and Mechanisms of Macrolide Resistance in Clinical Isolates of Group A Streptococci from Ontario, Canada. Antimicrob. Agents Chemother. 43: 2144-2147 [Abstract] [Full Text]  
  • Arpin, C., Canron, M.-H., Maugein, J., Quentin, C. (1999). Incidence of mefA and mefE Genes in Viridans Group Streptococci. Antimicrob. Agents Chemother. 43: 2335-2336 [Full Text]  
  • Arpin, C., Canron, M.-H., Noury, P., Quentin, C. (1999). Emergence of mefA and mefE genes in beta-haemolytic streptococci and pneumococci in France. J Antimicrob Chemother 44: 133-134 [Full Text]  
  • Arpin, C., Daube, H., Tessier, F., Quentin, C. (1999). Presence of mefA and mefE Genes in Streptococcus agalactiae. Antimicrob. Agents Chemother. 43: 944-946 [Abstract] [Full Text]